Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19725
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHengartner, Michael Pascal-
dc.contributor.authorJakobsen, Janus C.-
dc.contributor.authorSørensen, Anders-
dc.contributor.authorPlöderl, Martin-
dc.date.accessioned2020-03-12T13:51:54Z-
dc.date.available2020-03-12T13:51:54Z-
dc.date.issued2020-
dc.identifier.issn1932-6203de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/19725-
dc.description.abstractIt has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS).de_CH
dc.language.isoende_CH
dc.publisherPublic Library of Science de_CH
dc.relation.ispartofPLOS ONEde_CH
dc.rightshttp://creativecommons.org/licenses/by/4.0/de_CH
dc.subject.ddc616.8: Neurologie und Krankheiten des Nervensystemsde_CH
dc.titleEfficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trialsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementAngewandte Psychologiede_CH
zhaw.organisationalunitPsychologisches Institut (PI)de_CH
dc.identifier.doi10.1371/journal.pone.0229381de_CH
dc.identifier.doi10.21256/zhaw-19725-
dc.identifier.pmid32101579de_CH
zhaw.funding.euNode_CH
zhaw.issue2de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.starte0229381de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume15de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedKlinische Psychologiede_CH
zhaw.author.additionalNode_CH
Appears in collections:Publikationen Angewandte Psychologie

Files in This Item:
File Description SizeFormat 
2020_Hengartner-etal_New-generation-antidepressants.pdf898.34 kBAdobe PDFThumbnail
View/Open
Show simple item record
Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. Plos One, 15(2), e0229381. https://doi.org/10.1371/journal.pone.0229381
Hengartner, M.P. et al. (2020) ‘Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials’, PLOS ONE, 15(2), p. e0229381. Available at: https://doi.org/10.1371/journal.pone.0229381.
M. P. Hengartner, J. C. Jakobsen, A. Sørensen, and M. Plöderl, “Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials,” PLOS ONE, vol. 15, no. 2, p. e0229381, 2020, doi: 10.1371/journal.pone.0229381.
HENGARTNER, Michael Pascal, Janus C. JAKOBSEN, Anders SØRENSEN und Martin PLÖDERL, 2020. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. PLOS ONE. 2020. Bd. 15, Nr. 2, S. e0229381. DOI 10.1371/journal.pone.0229381
Hengartner, Michael Pascal, Janus C. Jakobsen, Anders Sørensen, and Martin Plöderl. 2020. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One 15 (2): e0229381. https://doi.org/10.1371/journal.pone.0229381.
Hengartner, Michael Pascal, et al. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One, vol. 15, no. 2, 2020, p. e0229381, https://doi.org/10.1371/journal.pone.0229381.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.